CDSCO monthly lab alert
CDSCO NSQ alert, September 2026: 330 drug batches flagged
By Blacklisted editorial team· Published 20 Oct 2026· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its September 2026 alert, the Central Drugs Standard Control Organisation listed 330 drug batches that failed quality tests, 42 at central laboratories and 288 at state drug-testing laboratories, from 231 manufacturers across 215 products. The most common failure was other, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Folic Acid Tablets IP 0.4 mg, Salbutamol Sulphate Syrup IP, Iron Sucrose Injection USP.
330
Batches flagged
42 / 288
Central / state labs
Other
Top reason
231
Manufacturers
Batches per month, last 12 alerts
Oct 2025Sep 2026 · 330
Full list of NSQ batches, September 2026
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| surgical Gauze & Bandage Cloth | Batch 02Mfg Apr 2026 · Exp Mar 2029 | Sri Sandana Magalingam Textiles | Threads - ends, Picks, Mass, Length, widthOther | Drug Testing Laboratory, Chennai-6State lab |
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch 3C0635Mfg May 2026 · Exp Apr 2028 | Deep PharmaGujarat | DescriptionDescription | FDL, VadodaraState lab |
| XTPARA MF 100Suspension | Batch MFBL25006Mfg Jun 2025 · Exp May 2027 | Prosperity Drugs Pvt. LtdHimachal Pradesh | Suspension does not dispose uniformly on shaking - DescriptionDescription | DTL Jabalpur Madhya PradeshState lab |
| X-ray Detectble Labarotomy Sponges IS 10829 | Batch 05Mfg Jun 2026 · Exp May 2029 | Sri Sandana Magalingam Textiles | Threads per stated length-ends per dm and picks per dmOther | Drug Testing Laboratory, Chennai-6State lab |
| Vitamin D3 Oral Solution | Batch GBL26312Mfg Jul 2026 · Exp Dec 2027 | Gats Biotech Pvt. Ltd | The sample does not conform to declared formula, in respect Identity test for Cholecalciferol, hence spuriousSpurious | LUCKNOW, Uttar PradeshState lab |
| Vitamin C Tablets IP 500mg | Batch 501024-BG197Mfg Oct 2024 · Exp Sep 2026 | Biogenetic Drugs Pvt. LtdHimachal Pradesh | Almost all the tablets received for analysis shows brown-colored spots all over the surface of the tablets, when observed in normal daylight conditions with unaided eyes.Description | FDAL, MumbaiState lab |
| Vitamin C Tablets IP 500 mg ? Chewable | Batch T-250530Mfg Sep 2025 · Exp Aug 2027 | Daffohils Laboratories Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for ?Dissolution? performed.Dissolution | SDTL, Agartala, TripuraState lab |
| Ursodeoxycholic Acid Tablets IP 300 mg | Batch DT605068Mfg May 2026 · Exp Apr 2028 | Renowed LifesciencesUttarakhand | The sample does not conform to I.P. in respect of Assay.Assay | LUCKNOW, Uttar PradeshState lab |
| Ursodeoxycholic Acid Tablets IP | Batch GTF3302AMfg Nov 2024 · Exp Oct 2026 | Sun Pharma Laboratories LtdAssam | TEST FOR ASSAY (CONTENT) OF URSODEOXYCHOLIC ACID.Assay | DTL, DelhiState lab |
| Urja Urbpro Capsule | Batch URJA702Mfg May 2026 · Exp Apr 2029 | Urbofort SGNR (RAJ) | The Sample gives TLC And HPLC Identification Test for the Presence of Tadalafil. Found Content of Tadalafil: 8.67 mg Per Capsule. Hence, the Sample is declared as Spurious Vide Section 33-EEA(d) of Drugs And Cosmetics Act 1940 And Rules thereunder.Identification | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Tynol MF suspension fort | Batch AG25077Mfg Apr 2025 · Exp Mar 2027 | Ayushi Pharmaceuticals | Suspension does not dispose uniformly on shaking- DescriptionDescription | DTL Jabalpur Madhya PradeshState lab |
| Trypsin Chymotrypsin Tablets | Batch GT501845AMfg Feb 2026 · Exp Jan 2028 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to declared formula with respect to Enzymatic activity of Trypsin Chymotrypsin.Other | LUCKNOW, Uttar PradeshState lab |
| Trypsin Chymotrypsin Tablets | Batch SHT-27916Mfg Apr 2025 · Exp Mar 2028 | Sunvet HealthcareHimachal Pradesh | The sample does not conform to claim with respect to the test for 'Disintegration'.Disintegration | CDL, KolkataCDSCO lab |
| Thyroxine Tablets IP 25 mcg | Batch T-639Mfg May 2026 · Exp Apr 2028 | Jackson Laboratories Pvt. LtdPunjab | The sample does not conform to IP with respect to Assay of 'Thyroxine Sodium'.Assay | CDL, KolkataCDSCO lab |
| Thyroxine Sodium Tablets IP | Batch 16251875AMfg Dec 2025 · Exp Nov 2027 | Macleods Pharmaceuticals Ltd | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Thyroxine Sodium Tablets IP | Batch H26MAB011Mfg Jan 2026 · Exp Dec 2027 | Macleods Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to IP with respect to DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Thyroxine Sodium Tablets IP | Batch 16251692AMfg Nov 2025 · Exp Oct 2027 | Macleods Pharmaceuticals Ltd | The sample does not conform to IP with respect to dissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Telmisartan Tablets IP 40mg | Batch 493TTF002Mfg Jul 2025 · Exp Jun 2027 | Swiss Garnier Life SciencesHimachal Pradesh | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL , ErnakulamState lab |
| Telmisartan Tablets IP 40 mg | Batch CHPLT1346Mfg Feb 2026 · Exp Jan 2028 | Cureza Healthcare Pvt. LtdMadhya Pradesh | The sample does not conform to standard quality in respect to the test for ?Dissolution & Assay? performed.Assay | SDTL, Agartala, TripuraState lab |
| Telmisartan Tablets IP 40 mg | Batch TLB08B26CMfg Feb 2026 · Exp Jan 2028 | Bajaj Healthcare Ltd. R.S. No. 1818Gujarat | DESCRIPTION ? TABLETS HAVING BLACK SPOTS.Description | SDTL, UttarakhandState lab |
| Telmisartan And Metoprolol Succinate Extended Release Tablets (40 mg+50 mg) | Batch GLB26001Mfg Feb 2026 · Exp Jan 2028 | Glenmark Pharmaceuticals LtdMaharashtra | The sample does not conform to declared formula, in respect of content of TelmisartanOther | LUCKNOW, Uttar PradeshState lab |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP | Batch 18250527Mfg Oct 2025 · Exp Sep 2028 | Glenmark Pharmaceuticals LtdSikkim | The sample does not conform to IP in respect of Dissolution of TelmisartanDissolution | LUCKNOW, Uttar PradeshState lab |
| Telmisartan & Amlodipine Tablets I.P. | Batch DLT-260356Mfg May 2026 · Exp Apr 2028 | Daffohills Laboratories Pvt. LtdUttarakhand | ASSAY OF AMLODIPINE BESYLATE I.P ? Less than prescribed limit.Assay | SDTL, UttarakhandState lab |
| Tapentadol Tablets 225 mg | Batch T25-17Mfg Mar 2026 · Exp Feb 2030 | Opal HealthcareHaryana | The sample does not conforms to the claim with respect to Assay of Tapentadol Hydrochloride.Assay | DTL, JaipurState lab |
| Tamsulosin Hydrochloride Modified Release Tablets | Batch N2600542Mfg Feb 2026 · Exp Jan 2029 | Intas Pharmaceuticals Ltd.Samardung RoadSikkim | One extra peak of Dutasteride found on Chromatogram.Other | SDTL, UttarakhandState lab |
| Tamsulosin Hydrochloride (Modified Release) + Dutasteride Tablets | Batch N2503564Mfg Nov 2025 · Exp Oct 2028 | Intas Pharmaceuticals Ltd.Samardung RoadSikkim | ASSAY OF DUTASTERIDE I.P. ?Less than prescribed limit.Assay | SDTL, UttarakhandState lab |
| Suspension of Calcium with Vit. D3 & B12 with Banana Flavour | Batch NB26014Mfg Mar 2026 · Exp Aug 2027 | Naxpar Pharma Pvt. Ltd. 182Himachal Pradesh | ASSAY OF CALCIUM PHOSPHATE IP ?Less than prescribed limit.Assay | SDTL, UttarakhandState lab |
| Sucralfate & Povidone-Iodine Ointment | Batch 0F5008AMfg Jun 2025 · Exp May 2027 | Navkar LifesciencesHimachal Pradesh | Assay for Available IodineAssay | DTL, Bengaluru, KarnatakaState lab |
| Sodium Valproate Gastro-Resistant Tablets IP 200mg | Batch GT501554AMfg Dec 2025 · Exp Nov 2027 | Gnosis Pharmaceuticals Pvt. Ltd. Nahan RoadHimachal Pradesh | DissolutionDissolution | Drug Testing Laboratory, Chennai-6State lab |
| Sodium Chloride Injection IP (0.9% W/V)(NS) | Batch M1095013Mfg Sep 2025 · Exp Aug 2028 | Ultra Laboratories Pvt. LtdKarnataka | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Sodium Bicarbonate Enteric Coated Tablets 500 mg | Batch NPT-6304AMfg Mar 2026 · Exp Feb 2028 | Nathan Pharma Pvt. LtdHimachal Pradesh | The sample does not conform to manufactures specification with respect to the test for Disintegration.Disintegration | CDL, KolkataCDSCO lab |
| Serratiopeptidase & Diclofenac Potassium Tablets | Batch ST-25874Mfg Dec 2024 · Exp Nov 2026 | Sunvij Drugs Private LimitedGujarat | test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| Salbutamol Syrup I.P | Batch SVK25066Mfg Nov 2025 · Exp Oct 2027 | Labinduss Ltd | The sample does not conform to IP standards. If fails the test pH mentioned in the laboratory protocol as per IPpH | DTL, KonniState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6367Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pHpH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6369Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pHpH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6368Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pHpH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6370Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pH (Does not comply with the limits as per IP 2026)pH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6371Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pH (Does not comply with the limits as per IP 2026)pH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6366Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pH (Does not comply with the limits as per IP 2026)pH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6364Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pH (Does not comply with the limits as per IP 2026)pH | SDTL, PunjabState lab |
| Salbutamol Sulphate Syrup IP | Batch AS-6365Mfg Jul 2026 · Exp Jun 2028 | Yacca Pharmaceuticals Pvt. LtdUttarakhand | pH (Does not comply with the limits as per IP 2026)pH | SDTL, PunjabState lab |
| SPF 50 PA+++ Body Brightening Lotion | Batch C26781Mfg Mar 2026 · Exp Feb 2029 | Conor Cosmo India Pvt Ltd. Ambala Chandigarh HighwayChandigarh | The sample does not comply for content of mercury I.e. 208.47 PPM, which is more than the limits of 1 parts per million (1 ppm) as prescribed for finished cosmetic products under section 39 (5) (b) of cosmetics rules, 2020.Other | FDAL, MumbaiState lab |
| SITAGLIPTIN PHOSPHATE TABLETS IP 50mg | Batch UGT25954Mfg Jun 2025 · Exp May 2027 | Unimarck Healthcare LtdUttarakhand | Failed DescriptionDescription | DTL, PuducherryState lab |
| Roller Bandage (Bange cloth cut IS 863) | Batch 04Mfg Apr 2026 · Exp Mar 2029 | Sri Sandana Magalingam Textiles | Description, Threads and massDescription | Drug Testing Laboratory, Chennai-6State lab |
| Rolled Bandage As Per Schedule F(II) Unsterilized | Batch 687Mfg Oct 2025 · Exp Sep 2027 | Tulip SurgicalsRajasthan | The sample does not conform to claim as per Schedule F-(II) with respect to test of lengthOther | CDL, KolkataCDSCO lab |
| Rolled Bandage As Per Schedule F(II) Unsterilized | Batch 678Mfg Oct 2025 · Exp Sep 2027 | Tulip SurgicalsRajasthan | The sample does not conform to claim as per Schedule F-(II) with respect to the test for lengthOther | CDL, KolkataCDSCO lab |
| Ranitidine Oral Solution IP | Batch BGL260507Mfg May 2026 · Exp Apr 2028 | Bestcare Formulation PvtPuducherry | content- Ranitidine in Ranitidine HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Ranitidine Oral Solution IP | Batch SL253963Mfg Jan 2026 · Exp Dec 2027 | Star Filteration SystemsHimachal Pradesh | content- Ranitidine (in Ranitidine Hydrochloride)Other | Drug Testing Laboratory, Madurai-19State lab |
| Ranitidine Oral Solution IP | Batch LV24L-320Mfg Nov 2024 · Exp Oct 2026 | LV LifesciencesHimachal Pradesh | Assay for RanitidineAssay | RDTL, Hubli, KarnatakaState lab |
| Ramipril Tablets IP 2.5 mg | Batch TA26151Mfg Apr 2026 · Exp Mar 2028 | Saintlife Pharmaceuticals LtdUttarakhand | The sample does not conform to the I.P. with respect to Assay and Dissolution.Assay | DTL, JodhpurState lab |
| Rabeprazole Sodium Enteric coated & Domperidone Sustained Release Capsules | Batch CF10008AMfg Oct 2025 · Exp Sep 2027 | Hetvi Lifesciences Pvt. LtdGujarat | The sample does not conform to claim with respect to the Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules | Batch BCD-B0204GMfg Jan 2026 · Exp Dec 2027 | Broad Tab Pvt. LtdHaryana | The sample does not conforms to the claim with respect to Assay of Rabeprazole Sodium and Domperidone.Assay | DTL, JaipurState lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules | Batch CE-25022Mfg May 2025 · Exp Apr 2027 | Horizon Bioceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to declared formula, in respect of content of Rabeprazole sodiumOther | LUCKNOW, Uttar PradeshState lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules | Batch LGQ01/199/01Mfg Jan 2026 · Exp Jun 2027 | Logos PharmaHimachal Pradesh | The sample does not conform to declared formula in respect of content of Rabeprazole and Domperidone.Other | VARANASI, Uttar PradeshState lab |
| Rabeprazole Gastro-Resistant Tablets IP | Batch SPA252793Mfg Dec 2025 · Exp Nov 2027 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Dissolution (Buffer Stage)Dissolution | RDTL, ChandigarhCDSCO lab |
| Rabeprazole Gastro Resistant Tablets IP 20 mg | Batch GFTB25844Mfg Sep 2025 · Exp Aug 2027 | Genip Formulation Pvt LtdHimachal Pradesh | Assay & Dissolution Test of RabeprazoleAssay | SDTL, Andhra Pradesh, VijayawadaState lab |
| Rabeprazole Gastro Resistant Tablets IP | Batch GFTB26191Mfg Apr 2026 · Exp Mar 2028 | Genip Formulation Pvt LtdHimachal Pradesh | Dissolution Test of RabeprazoleDissolution | SDTL, Andhra Pradesh, VijayawadaState lab |
| RABEPRAZOLE SODIUM TABLETS IP | Batch MDT-4228Mfg Jul 2025 · Exp Jun 2027 | Mayasha LifesciencesHimachal Pradesh | Failed Description, Disintegration and AssayAssay | DTL, PuducherryState lab |
| Promethazine Injection I.P. | Batch HLI992MMfg Dec 2025 · Exp Nov 2027 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conform to I.P. with respect to the Tests of pH and Assay.Assay | CDL, KolkataCDSCO lab |
| Promethazine HCl Injection IP | Batch 26FND32Mfg Apr 2026 · Exp Mar 2028 | SVP Life SciencesUttarakhand | The sample does not conform to I.P. in the respect of Assay and Particulate matter.Assay | ALIGARH, Uttar PradeshState lab |
| Promethazine HCL Injection IP | Batch 25FNL70Mfg Dec 2025 · Exp Nov 2027 | SVP Life SciencesUttarakhand | The sample does not conforms to I.P. in the respect of content of Promethazine HCI & pH.pH | ALIGARH, Uttar PradeshState lab |
| Povidone-Iodine Solution IP 5% w/v | Batch 35Mfg Aug 2025 · Exp Jul 2027 | Daxin Pharmaceuticals Pvt. LtdHimachal Pradesh | Assay for Available-IodineAssay | DTL, Bengaluru, KarnatakaState lab |
| Piperazine Citrate Syrup | Batch 220626Mfg Jun 2026 · Exp May 2028 | Uniplus Biotech (P) Ltd | The sample does not conform to declared formula, in respect of Content of Piperazine Citrate & gives negative identity for Diethylene Glycol (DEG) & Ethylene Glycol LEGOther | LUCKNOW, Uttar PradeshState lab |
| Piperacillin & Tazobactam Inj I.P -4.5gm | Batch 333609Mfg Mar 2026 · Exp Feb 2028 | Zazen Pharma Pvt. Ltd | content- PiperacillinOther | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Phenytoin Sodium Tablets I.P 100 mg | Batch T01260980Mfg Jan 2026 · Exp Dec 2027 | Sidhbali FormulationsUttarakhand | DescriptionDescription | RDTL, Hubli, KarnatakaState lab |
| Permethrin, Cetrimide & Aloevera soap | Batch BS-022607Mfg Feb 2026 · Exp Jan 2028 | Biowil FormulationUttarakhand | content- PermethrinOther | Drug Testing Laboratory, Chennai-6State lab |
| Peritoneal Dialysis Solution with 2.5% Dextrose IP | Batch A25D043Mfg Apr 2025 · Exp Apr 2027 | Baxter Manufacturing (Thailand) Co. Ltd. Imported by- Baxter (India) Pvt. Ltd. No. Ambattur TalukTamil Nadu | The sample does not conforms to claim as per IP 2022 in respect to the Description, Appearance of Solution, Particulate Matter and Bacterial EndotoxinsDescription | DTL BADDIState lab |
| Peritoneal Dialysis Solution with 1.5% Dextrose IP | Batch A25E044Mfg May 2025 · Exp May 2027 | Baxter Manufacturing (Thailand) Co. Ltd. Imported by- Baxter (India) Pvt. Ltd. No. Ambattur TalukTamil Nadu | The sample does not conform to claim as per IP 2022 in respect to the Test of Bacterial EndotoxinsBacterial endotoxins | DTL BADDIState lab |
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate and Caffeine Tablets | Batch DRT25284Mfg Sep 2025 · Exp Aug 2027 | Eastern HealthcareUttarakhand | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets | Batch DHPLT/030725Mfg Jul 2025 · Exp Jun 2027 | Durgaji Healthcare Pvt.LtdUttarakhand | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules 1945 with respect to test for 'Disintegration Time' and is also not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab |
| Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension | Batch SKL260238Mfg Mar 2026 · Exp Feb 2028 | S Kins PharmaHimachal Pradesh | The sample does not coform to the claim to the prescribed standard for Patent & Proprietary medicine with respect to the assay of menthol.Assay | Drug Testing Laboratory, Baddi, Solan, H.PState lab |
| Paracetamol Tablets IP 650 mg, | Batch CAAL25019Mfg Apr 2025 · Exp Mar 2028 | Curetech Formulations Pvt. LtdHimachal Pradesh | Sample does not conform to IP standards. It fails the test Dissolution.Dissolution | RDTL , ErnakulamState lab |
| Paracetamol Tablets IP 650 mg | Batch TV6122Mfg Aug 2026 · Exp Jul 2028 | Alpa Laboratories LtdMadhya Pradesh | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab |
| Paracetamol Tablets IP 650 mg | Batch IPCL25017Mfg Mar 2025 · Exp Feb 2028 | Pinnacle Life Science Pvt LtdHimachal Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Paracetamol Tablets IP 500mg | Batch PCTJ26007Mfg Mar 2026 · Exp Feb 2028 | Vivek Pharmaceuticals Pvt. LtdJammu & Kashmir | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab |
| Paracetamol Tablets IP 500 mg | Batch PAK-815Mfg Nov 2024 · Exp Oct 2027 | Healer's Lab Unit IIHimachal Pradesh | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab |
| Paracetamol Sustained Release Tablets USP | Batch BRD240848AMfg Dec 2024 · Exp Nov 2027 | BRD Medilabs (Unit-II)Himachal Pradesh | Sample does not conform to USP Standards. It fails the test Dissolution as per USP.Dissolution | RDTL , ErnakulamState lab |
| Paracetamol Phenylepherine Hydrochloride Caffine (Anhydrous) Diphenhydramine Hydrochloride | Batch T-2511129Mfg Nov 2025 · Exp Oct 2027 | Aagya Biotech Pvt. Ltd. 1.5 kmUttarakhand | DescriptionDescription | SDT&RL, BhubanesearState lab |
| Paracetamol Paediatric Oral Suspension IP | Batch PAMLA002Mfg Aug 2025 · Exp Jul 2027 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The sample does not conform to IP in respect of content of Paracetamol.Other | LUCKNOW, Uttar PradeshState lab |
| Paracetamol IP 500 mg Tablets | Batch APRCT-2501Mfg May 2025 · Exp Apr 2027 | Konis Pharmaceuticals Pvt. LtdHimachal Pradesh | Sample Does not meets the Specifications wrt, Assay and Dissolution Test as per IP.Assay | State Lab, DCL, TelanganaState lab |
| Pantoprazole for Injection IP | Batch YMC-2534Mfg Sep 2025 · Exp Aug 2027 | Park PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per I.P. Addendum 2024 in respect to the Test of SterilitySterility | RDTL, GuwahatiCDSCO lab |
| Pantoprazole Sodium Gastro-resistant Tablets IP' | Batch 26KHT-0255Mfg Feb 2026 · Exp Jan 2028 | Kaalinga Health CareHimachal Pradesh | The Sample does not conform to the IP standards with respect to the tests Dissolution and Assay.Assay | DTL, ThrissurState lab |
| Pantoprazole Sodium Gastro Resistant tablets IP 40 mg | Batch OM-12884Mfg Apr 2026 · Exp Mar 2025 | D.D. Pharmaceutical Pvt. Ltd. G-1/583Rajasthan | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | Batch ACTD-05Mfg Jan 2026 · Exp Dec 2027 | Nestor Pharmaceuticals LimitedHaryana | The sample received does not conform to i.p. 2022, i.p. addendum 2024 specification with respect to the test for Dissolution (acid stage) onlyDissolution | CDTL, HyderabadCDSCO lab |
| Pantoprazole Gastro Resistant Tablets IP 40 mg | Batch THE26003ALMfg Apr 2026 · Exp Mar 2028 | Hindustan Laboratories LimitedMaharashtra | Dissolution TestDissolution | SDTL, Andhra Pradesh, VijayawadaState lab |
| Pantoprazole Gastro Resistant Tablets IP 40 mg | Batch PGR018Mfg Nov 2025 · Exp Oct 2027 | RTN Pharma | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Pantoprazole For Injection I.P. | Batch SPDD-001BMfg Apr 2026 · Exp Mar 2028 | Sai Pharma Pvt. LtdHaryana | The sample does not conform to I.P. in the respect of Assay.Assay | ALIGARH, Uttar PradeshState lab |
| Pantoprazole & Domperidone Tablets | Batch SRGT-25971Mfg Nov 2025 · Exp Oct 2027 | Spas RemediseHimachal Pradesh | Test for DisintegrationDisintegration | RDTL, Bellary, KarnatakaState lab |
| PARACETAMOL PAEDIATRIC ORAL SUSPENSION | Batch PAD1130Mfg Feb 2026 · Exp Jan 2028 | REVIVE Formulations India Pvt. LtdTamil Nadu | Misbranded-Incorrect LabellingMisbranded | DTL, PuducherryState lab |
| PARACETAMOL AND TRAMADOL TABLETS IP | Batch DT644Mfg Jul 2025 · Exp Jun 2027 | Prim Drugs & Pharmaceuticals (I) Pvt. LtdTamil Nadu | Failed Disintegration and DissolutionDissolution | DTL, PuducherryState lab |
| Oxytocin Injection IP | Batch IA26-64Mfg Jan 2026 · Exp Dec 2027 | Om Biomedic Pvt. LtdUttarakhand | The sample does not comply I.P. 2022 with respect to the test for "Bacterial Endotoxins and Sterility" of Oxytocin Injections.Sterility | RDTL, GuwahatiCDSCO lab |
| Oxytetracycline Dihydrate Injection I.P. (VET) -30ml/LA | Batch OLU25001Mfg Apr 2025 · Exp Mar 2027 | Vivek Pharmaceuticals Pvt. LtdJammu & Kashmir | pH and BETpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Oxyclozanide & Levamisole Hydrochloride Bolus | Batch SF26-069Mfg Jun 2026 · Exp May 2028 | Safecon Lifesciences Pvt. Ltd | The sample does not conform to declared formula, in respect of DisintegrationDisintegration | LUCKNOW, Uttar PradeshState lab |
| Oxfendazole Veterinary Oral Suspension (Vet) | Batch PFV100925Mfg Sep 2025 · Exp Aug 2027 | Padmaja Laboratories Pvt LtdAndhra Pradesh | Sample does not comply test parameter pH as per IP 2022 (Vet).pH | State Lab, DCL, TelanganaState lab |
| Oxandrolone Tablets USP 10 mg | Batch TDB24009Mfg Mar 2024 · Exp Feb 2028 | Thaiger Pharma | The sample does not conform to U.S.P. with respect to the tests for 'Identification' and 'Assay' of 'Oxandrolone'.Assay | CDL, KolkataCDSCO lab |
| Oral Rehydration Salts IP 20.5 gm | Batch P24/1219Mfg Jan 2025 · Exp Dec 2026 | SamkemMadhya Pradesh | The Sample does not conform to IP Standards. If fails the 'Descriptive Part' for Oral Rehydration Salts as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab |
| Ondansetron Orally Disintegration Tablets IP | Batch SBT-456Mfg Sep 2025 · Exp Aug 2027 | Sarthak Biotech Pvt. Ltd | The sample does not conform to IP standards. It fails the test Dissolution as per IPDissolution | RDTL , ErnakulamState lab |
| Ondansetron Hydrochloride Injection IP | Batch NON 09Mfg Jul 2026 · Exp Jun 2028 | PAR Pharmaceuticals Pvt. LtdUttarakhand | The sample does not conform to I.P. in respect of Particulate Matter & Extractable Volume.Particulate matter | LUCKNOW, Uttar PradeshState lab |
| Omeprazole Gastro-resistant Capsules IP 20 mg | Batch 25281124Mfg Jun 2025 · Exp May 2027 | Alkem Laboratories LtdHimachal Pradesh | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Omeprazole Capsules IP | Batch 272516Mfg Nov 2025 · Exp Oct 2027 | Towa Pharma Private Limited | Content of OmeprazoleOther | FDL, VadodaraState lab |
| Omeprazole & Domperidone Capsules IP | Batch C-2873Mfg Oct 2025 · Exp Sep 2027 | Supercure Biotech Pvt. LtdHaryana | The sample does not conform to IP in respect of Uniformity of Content.Uniformity of weight/content | LUCKNOW, Uttar PradeshState lab |
| Olmesartan Medoxomil, chlorthalidone And Clinidipine Tablets | Batch LMT26074Mfg Feb 2026 · Exp Jan 2028 | Alwashank Life Max Cancer LaboratoriesUttarakhand | The Content of Cilnidipine in the Sample is less i.e. 51.80% of Stated Amount) than Schedule V Limit. (Schedule V Limit:- Not less than 90% and Not More than 110% of Stated Amount)Other | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Olmesartan Medoxomil, Hydrochlorothiazide | Batch GT35462AMfg Jul 2026 · Exp Jun 2028 | J.M. LaboratoriesHimachal Pradesh | The sample does not conforms to the claim with respect to Assay of Olmesartan Medoxomil.Assay | DTL, JaipurState lab |
| Olmesartan Medoxomil Amlodipine & Hydrochlorothiazide Tablets | Batch Q15Y005Mfg Dec 2025 · Exp Nov 2027 | MANKIND PHARMA LTD. Doring BlockSikkim | The sample does not conform to declared formula, in respect of content of Olmesartan Medoxomil and Amlodipine.Other | LUCKNOW, Uttar PradeshState lab |
| Olivia Gold Bleach Saffron | Batch 5051Mfg Feb 2025 · Exp Jan 2027 | Herbs De OliviaUttarakhand | The sample does not conforms to the requirements of Indian Standard (IS 15608: 2018) with respeet to the test for pH of the Activator.pH | LUCKNOW, Uttar PradeshState lab |
| Olanzapine Tablets IP 5 mg | Batch EOCT1313Mfg Jul 2025 · Exp Jun 2027 | Unicure India LtdUttar Pradesh | The sample does not conform to IP standards with respect to the test Assay.Assay | DTL, ThrissurState lab |
| Ofloxacin Tablets IP 200 mg | Batch T25H531BMfg Aug 2025 · Exp Jul 2027 | Bajaj FormulationsUttarakhand | TESTS FOR UNIFORMITY OF WEIGHTUniformity of weight/content | DTL, DelhiState lab |
| Ofloxacin IP, Ornidazole IP, Lopramide IP | Batch DL-1401Mfg Jan 2026 · Exp Dec 2027 | Dutch Formulations 32Himachal Pradesh | Description, Labelling, Assay and MisbrandedAssay | CFDL JammuState lab |
| Ofloxacin & Ornidazole Tablets IP | Batch 12840Mfg Jun 2026 · Exp May 2028 | Oyster Labs LtdHaryana | The sample does not conform to I.P. in respect of Content of OrnidazoleOther | Gorakhpur, Uttar PradeshState lab |
| Non Woven Adhesive Tape B.P. 88 (Paper Adhesive Plaster) Size: 2 inch x 9m with cutter | Batch RM-2-15Mfg Aug 2024 · Exp Jul 2027 | Tulip SurgicalsRajasthan | The sample does not conform to claim as per B.P. 88 in respect to the Test of Weight Of Backing MaterialWeight | CDL, KolkataCDSCO lab |
| Nitrazepam Tablets IP 10 mg | Batch NT-2622Mfg Feb 2026 · Exp Jan 2028 | Addapt Life Care Pvt.LtdUttarakhand | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL , ErnakulamState lab |
| Nifedipine Sustained Release Tablets IP 10 mg | Batch ACG25007Mfg Jun 2025 · Exp May 2028 | J.B. Chemicals & Pharmaceuticals LtdGujarat | Dissolution (Stage A)Dissolution | FDL, VadodaraState lab |
| Nicorandil Tablets IP 5mg | Batch T26A675AMfg Jan 2026 · Exp Dec 2027 | Bajaj FormulationsUttarakhand | The sample is not of standard quality in respect of Assay.Assay | LUCKNOW, Uttar PradeshState lab |
| Nicorandil IP | Batch PT-052509Mfg May 2025 · Exp Apr 2027 | Primus Pharmaceuticals sadhoura road Mauza Ogli KhariHimachal Pradesh | Description, Dissolution and AssayAssay | CFDL JammuState lab |
| Nicardia Retard 10 Tablet | Batch ACG25007Mfg Jun 2025 · Exp May 2028 | J.B.Chemicals & Pharmaceuticals LtdDaman & Diu | Dissolution.Dissolution | FDL, VadodaraState lab |
| Neomycin Sulphate, Beclomethasone Dipropionate, Clotrimazole & Lignocaine Hydrochloride Ear Drops | Batch OP302501AMfg Jul 2025 · Exp Jun 2027 | Protech TelelinksHimachal Pradesh | The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Rules with respect to Assay of Neomycin Sulphate, Beclomethasone Dipropionate and ClotrimazoleAssay | CDL, KolkataCDSCO lab |
| Nebulizer Mask Peaditric with Chamber and Tubing. | Batch R26NMCG001Mfg Feb 2026 · Exp Jan 2029 | Rudraksh Pharma & Surgico Pvt. Ltd. 176/6Gujarat | SterilitySterility | FDL, VadodaraState lab |
| Multi-Vitamin Tablets | Batch T-9108Mfg Mar 2026 · Exp Feb 2028 | Jackson Laboratories Pvt. LtdPunjab | The sample does not conform to Manufacturer's Specification with respect to the test for Microbial Limit Test with regards to 'Total aerobic viable count'Microbial limits | CDL, KolkataCDSCO lab |
| Moxifloxacin Hydrochloride, Ornidazole, Urea with Vitamin E & Citrus Bioflovonoids Solution | Batch GUV1025/01Mfg Oct 2025 · Exp Sep 2027 | Gurshyam Formulations Pvt. Ltd | The sample does not conform to declared formula, in respect of content of Moxifloxacin Hydrochloride and OrnidazoleOther | LUCKNOW, Uttar PradeshState lab |
| Mounjaro Kwikpen 15 mg/0.6ml | Batch D949932Mfg ? · Exp ? | Eli Lilly Italiy Spa Antonio Gram Sci 731/733 SestoMaharashtra | The sample does not pass the test for Assay.Assay | Govt. Analyst, Haryana, ChandigarhState lab |
| Mounjaro Kwikpen 12.5 mg/0.6ml | Batch D894806Mfg ? · Exp ? | Eli Lilly Italiy Spa Antonio Gram Sci 731/733 SestoMaharashtra | The sample does not pass the test for Assay.Assay | Govt. Analyst, Haryana, ChandigarhState lab |
| Mounjaro KwikPen 7.5mg/0.6ml | Batch D938368Mfg ? · Exp ? | Eli Lilly Italiy Spa Antonio Gram Sci 731/733 SestoMaharashtra | The sample does not pass the test for Assay.Assay | Govt. Analyst, Haryana, ChandigarhState lab |
| Mounjaro KwikPen 5mg/0.6ml | Batch D928027Mfg ? · Exp ? | Eli Lilly Italiy Spa Antonio Gram Sci 731/733 SestoMaharashtra | The sample does not pass the test for Assay, Sterility and Related Substance/Impurities.Assay | Govt. Analyst, Haryana, ChandigarhState lab |
| Mounjaro KwikPen 2.5mg/0.6ml | Batch D924668Mfg ? · Exp ? | Eli Lilly Italiy Spa Antonio Gram Sci 731/733 SestoMaharashtra | The sample does not pass the test for Assay and Sterility.Assay | Govt. Analyst, Haryana, ChandigarhState lab |
| Mounjaro KwikPen 10mg/0.6ml | Batch D949702Mfg ? · Exp ? | Eli Lilly Italiy Spa Antonio Gram Sci 731/733 SestoMaharashtra | The sample does not test for Assay and Related Substance/Impurities.Assay | Govt. Analyst, Haryana, ChandigarhState lab |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP | Batch FMT26015SLMfg Apr 2026 · Exp Mar 2028 | Shiva Biogenetic Laboratories Pvt. LtdHimachal Pradesh | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets | Batch ZDTY030Mfg Dec 2025 · Exp Nov 2027 | Pro-pharma Care Pvt. LtdUttarakhand | The sample dose not conform to I.P., in respect of Uniformity of content and DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP | Batch T260356KMfg Mar 2026 · Exp Feb 2028 | Unispeed Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Montelukast Sodium & Levcocetirizine Hydrochloride Tablets IP | Batch D25M01MEMfg Dec 2025 · Exp Nov 2027 | Mapra Laboratories Pvt. LtdDaman & Diu | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab |
| Metronidazole, Furazolidone & Loperamide HCL Bolus (Vet) | Batch WT-002Mfg Mar 2025 · Exp Feb 2027 | Therawin FormulationsHaryana | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| Methylprednisolone Tablets IP 16 mg | Batch BLM03ACAMfg Nov 2025 · Exp Oct 2027 | Malik Lifesciences Pvt. LtdUttarakhand | Sample does not conforms to Indian Pharmacopiea 2026 standards. This particular batch of sample fails in the test " Dissolution".Dissolution | RDTL , ErnakulamState lab |
| Metformin Tablets I.P. 500 mg | Batch SMF-103Mfg Jun 2025 · Exp May 2027 | MARC Life Sciences SikkimSikkim | TESTS PERFORMED FOR UNIFORMITY OF WEIGHT.Uniformity of weight/content | DTL, DelhiState lab |
| Meloxicam, Paracetamol And Serratiopeptidase Bolus (Vet) | Batch PT25367Mfg Dec 2025 · Exp May 2028 | Prispag PharmaPunjab | Uneven Light Brown Coloured Spots are observed on the Surface of Almost all the Bolus.Description | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Meloxicam and Paracetamol Bolus (Vet) | Batch Nov-21Mfg Apr 2026 · Exp Mar 2028 | Unitech Pharmaceuticals (India) | DescriptionDescription | RDTL, Bellary, KarnatakaState lab |
| Mefenamic Acid and Paracetamol Tablets | Batch T3209Mfg May 2024 · Exp Apr 2027 | Jersy Pharma | Assay for Mefenamic AcidAssay | DTL, Bengaluru, KarnatakaState lab |
| Mebendazole IP & Ivermectin IP Vet Oral Powder | Batch VBC-0116Mfg Jan 2026 · Exp Jul 2027 | Cure Quick PharmaceuticalsHaryana | The sample does not conform to declared formula in respect of Content of Ivermectin.Other | MEERUT, Uttar PradeshState lab |
| Lorazepam Tablets IP 2 mg | Batch 4660Mfg Mar 2026 · Exp Feb 2030 | Reliance Formulations Pvt. LtdGujarat | The sample does not conform to I. P. in respect of Assay. (Content of Lorazepam)Assay | Gorakhpur, Uttar PradeshState lab |
| Lorazepam Tablets I.P. | Batch T-270162Mfg Apr 2026 · Exp Mar 2028 | Merril Pharma Pvt. LtdUttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution (after 30 min) and Dissolution (after 60 min)Dissolution | RDTL, ChandigarhCDSCO lab |
| Loperamide Hydrochloride Tablets IP 2 mg- | Batch SBT-3269Mfg Jul 2025 · Exp Jun 2027 | Supercure Biotech Pvt. LtdHaryana | Sample does not conform to IP standards. This particular batch of sample fails in the tests'dissolution and assay of Loperamide Hydrochloride.Assay | RDTL , ErnakulamState lab |
| Loperamide Hydrochloride Tablets IP 2 mg | Batch LOF-26002Mfg Apr 2026 · Exp Mar 2029 | Okvik Pharma Pvt. LtdHaryana | The sample does not conform to IP in respect of Assay & DissolutionAssay | LUCKNOW, Uttar PradeshState lab |
| Loperamide Hydrochloride Tablets IP 2 mg | Batch LOP-25014Mfg Feb 2026 · Exp Jan 2029 | Okvik Pharma Pvt. LtdHaryana | The sample does not conform to I. P. in respect of Assay. (Content of Loperamide Hydrochloride)Assay | Gorakhpur, Uttar PradeshState lab |
| Liquid Paraffin, Magnesium Hydroxide, Sodium Picosulfate Suspension | Batch MPL254485Mfg Nov 2025 · Exp Oct 2027 | Aristo Pharmaceuticals Pvt. Ltd | Description onlyDescription | RDTL, Hubli, KarnatakaState lab |
| Linezolid Tablets IP 600mg | Batch TG261185Mfg May 2026 · Exp Apr 2028 | Symbiosis Pharmaceuticals Pvt. LtdHimachal Pradesh | DissolutionDissolution | DTL BaddiState lab |
| Levosalbutamol, Guaiphenesin & Ambroxol Hydrochloride syrup | Batch UFL251248KMfg Dec 2025 · Exp Nov 2027 | Ultra Drugs Formulations Pvt LtdHimachal Pradesh | content- Ambroxol HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup | Batch TS-399Mfg Aug 2025 · Exp Jul 2027 | Trimedix Pharma (P) LtdPunjab | TESTS FOR ASSAY (CONTENT) OF AMBROXOL HYDROCHLORIDEAssay | DTL, DelhiState lab |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup | Batch AGL51232Mfg Dec 2025 · Exp Nov 2027 | Alventa Pharma LtdHimachal Pradesh | content - Levosalbutamol(in Levosalbutamol Sulphate) and Ambroxol HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Levocetirizine Tablets IP 5mg | Batch 0726A021Mfg Jan 2026 · Exp Dec 2027 | FDC LimitedGoa | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Levocetirizine Hydrochloride, Ambroxol Hydrochlolride | Batch 26LK024Mfg Jan 2026 · Exp Jan 2028 | Kantil Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not comply with the prescribed requirement for 'Description'Description | DTL, Dalgate Srinagar KashmirState lab |
| Levocetirizine Hydrochloride & Montelukast Sodium tablets IP | Batch UGT-25627LMfg May 2025 · Exp Apr 2027 | Ultra Drugs Pvt. LtdHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Levocetirizine Dihydrochloride 5mg Tablets IP | Batch MPR-251105Mfg Nov 2025 · Exp Oct 2027 | Preet Remedies LtdHimachal Pradesh | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Levocetirizine Dihydrochloride & Montelukast Tablets IP | Batch LGP12/303/37Mfg Dec 2025 · Exp Nov 2027 | Logos PharmaHimachal Pradesh | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab |
| Levetiracetam Tablets IP 500 mg | Batch N2601077Mfg Apr 2026 · Exp Mar 2029 | Intas Pharmaceuticals LtdSikkim | The sample does not conform to IP with respect to Dissolution and The sample does not meet the labelling requrements of IP 2022 and Rules 96 (IV) of the D & C Rules 1945, Hence MisbrandedDissolution | LUCKNOW, Uttar PradeshState lab |
| Levetiracetam Tablets IP 500 mg | Batch N2600803Mfg Mar 2026 · Exp Feb 2029 | Intas Pharmaceuticals LtdSikkim | The sample does not conform to IP in respect of Dissolution.Dissolution | LUCKNOW, Uttar PradeshState lab |
| Levetiracetam Tablets IP 500 mg | Batch N2601623Mfg May 2026 · Exp Apr 2029 | Intas Pharmaceuticals LtdSikkim | The sample does not conform to IP with respect to Dissolution and The sample does not meet the labelling requrements of the D & C Act 1940 and Rules thereunder, Hence MisbrandedDissolution | LUCKNOW, Uttar PradeshState lab |
| Lansoprazole Orally Disintegrating Tablets 15mg | Batch AT-2139AMfg Oct 2025 · Exp Sep 2027 | Azot Life SciencesHimachal Pradesh | content - LansoprazoleOther | Drug Testing Laboratory, Madurai-19State lab |
| Lactulose Solution IP 10 gm/15ml | Batch GL500941AMfg Mar 2026 · Exp Feb 2028 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. Addendum 2024 with respect to the tests of Description and Assay of LactuloseAssay | CDL, KolkataCDSCO lab |
| Lactulose Solution IP 10 gm/15ml | Batch GL500942AMfg Mar 2026 · Exp Feb 2028 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. Addendum 2024 with respect to the tests of Description and Assay of LactuloseAssay | CDL, KolkataCDSCO lab |
| L-Carnitine L-Tartrate, Mecobalamin & Folic Acid Tablets | Batch B95Z020Mfg Feb 2026 · Exp Jan 2028 | Mankind Pharma LtdSikkim | The sample gave identity test Negative for Mecobalamin & Folic Acid, Hence spuriousSpurious | LUCKNOW, Uttar PradeshState lab |
| L-Carnitine L-Tartrate, Mecobalamin & Folic Acid Tablets | Batch B95Y032Mfg Mar 2025 · Exp Feb 2027 | Mankind Pharma LtdSikkim | The sample gives Negative Identity test for Mecobalamin & Folic Acid, Hence the sample is SpuriouOther | LUCKNOW, Uttar PradeshState lab |
| Ketoconazole, lodochlorhydroxyquinoline, Neomycin, Tolnaftate, Clobetasol Propionate and D Panthenol Cream | Batch 6093Mfg May 2026 · Exp Apr 2028 | Samson Laboratories Pvt. LtdHimachal Pradesh | The sample does not conform to declared formula in respect of content of Clobetasole PropionateOther | Gorakhpur, Uttar PradeshState lab |
| Ketoconazole, Zinc Pyrithione & Glycerine Soap | Batch 25120324Mfg Dec 2025 · Exp Nov 2027 | Astonea Labs Pvt. LtdHaryana | The sample does not conform to declared formula, in respect of content of Ketoconazole and Zinc Pyrithione.Other | LUCKNOW, Uttar PradeshState lab |
| Ketoconazole medicated soap | Batch 9411Mfg Nov 2025 · Exp Oct 2027 | Vimson DermaGujarat | content - KetoconazoleOther | Drug Testing Laboratory, Madurai-19State lab |
| Ketoconazole cream 2% w/w | Batch 6P36Mfg Apr 2026 · Exp Mar 2028 | Yacca Lifesciences Pvt LtdUttarakhand | content- KetoconazoleOther | Drug Testing Laboratory, Chennai-6State lab |
| Itraconazole Capsules 200mg | Batch B23225007Mfg Aug 2025 · Exp Jul 2027 | Torque Pharmaceuticals Pvt. Ltd | The sample does not conform to claim with respect to test for Dissolution.Dissolution | CDL, KolkataCDSCO lab |
| Itraconazole Capsules 100 mg | Batch C60015Mfg Jan 2026 · Exp Dec 2027 | Zenith Drugs Pvt. LtdMadhya Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Iron Sucrose Injection USP | Batch MFS-117Mfg Oct 2025 · Exp Sep 2027 | Marc Laboratories Ltd. (Unit III)Himachal Pradesh | The sample does not conform to U.S.P with respect to test for 'Alkalinity' and 'pH'pH | CDL, KolkataCDSCO lab |
| Iron Sucrose Injection USP | Batch MFS-134Mfg Dec 2025 · Exp Nov 2027 | Marc Laboratories Ltd. (Unit III)Himachal Pradesh | The sample does not conform to U.S.P with respect to the Test for "pH' and 'AlkalinitypH | CDL, KolkataCDSCO lab |
| Iron Sucrose Injection USP | Batch MFS-129Mfg Dec 2025 · Exp Nov 2027 | Marc Laboratories Ltd. (Unit III)Himachal Pradesh | The sample does not conform to U.S.P with respect to test for "Alkalinity" and "pH".pH | CDL, KolkataCDSCO lab |
| Iron Sucrose Injection USP | Batch MFS-133Mfg Dec 2025 · Exp Nov 2027 | Marc Laboratories Ltd. (Unit III)Himachal Pradesh | The sample does not conform to U.S.P with respect to test for 'Alkalinity' and 'pH'pH | CDL, KolkataCDSCO lab |
| Iron Sucrose Injection USP | Batch MFS-136Mfg Jan 2026 · Exp Dec 2027 | Marc Laboratories Ltd. (Unit III)Himachal Pradesh | The sample does not conform to U.S.P with respect to test for 'pH' and 'Alkalinity'.pH | CDL, KolkataCDSCO lab |
| Ibuprofen Tablets IP 400 mg | Batch IBK-2601Mfg Feb 2026 · Exp Jan 2029 | Askon Health Care | The sample does not conform to standard quality in respect of the test for ?Dissolution? performed.Dissolution | SDTL, Agartala, TripuraState lab |
| Ibuprofen &Paracetamol Tablets IP | Batch KFM-2501Mfg Mar 2025 · Exp Feb 2028 | Askon Health Care | The sample does not conform to standard quality in respect of the test for ?Dissolution? and Description performed.Dissolution | SDTL, Agartala, TripuraState lab |
| Ibuprofen & Paracetamol Tablets | Batch OT-13158Mfg Jun 2026 · Exp May 2028 | Omnison Pharma (P) Ltd. G-456 & 457 | The sample does not conform to standard, in respect of Uniformity of Dispersion.Uniformity of weight/content | LUCKNOW, Uttar PradeshState lab |
| IBUCARE PLUS TABLETS | Batch IT6183Mfg May 2026 · Exp Apr 2029 | Inducare Pharmaceutical And Research Foundation Pvt. Ltd. G-32Maharashtra | THE SAMPLE DOES NOT GIVE I.P. IDENTIFICATION TEST FOR THE PRESENCE OF IBUPROFEN. THEREFORE, THE DRUG IS DECLARED AS SPURIOUS VIDE SECTION 17-B OF THE DRUGS AND COSMETICS ACT 1940 AND COSMETICS ACT 1945 THEREUNDER.Identification | FDAL, MumbaiState lab |
| Hydroquinon Tretinoin& Mometasone Furoate Cream | Batch 26128AMfg Mar 2026 · Exp Feb 2028 | Athens Life SciencesHimachal Pradesh | The Assay of Mometasone FuroateAssay | DTL BaddiState lab |
| Haemostatic Tablets | Batch ST26052Mfg Feb 2026 · Exp Jan 2028 | Shrinivas (Gujarat) Laboratories Pvt. LtdGujarat | The sample does not conform to Manufacturer's Specification with respect to Description test.Description | CDL, KolkataCDSCO lab |
| Goree Day & Night Beauty Cream | Batch GDN185Mfg Jul 2025 · Exp Jun 2028 | Goree Cosmetics (pvt)Ltd | 1) The Sample does not Comply for Content of Mecrury i..e. 47477.53 ppm which is more than the Limits of 1 Part per million (I ppm) as Prescribed for finished Cosmetic Products under Rule 39 (5)(b) of Cosmetic Rule 2020. 2) The Sample gives Identification for the Presence of Hydroquinone, Hence the Sample is declared as Spurious Vide Rule 17-D(b) of Drug And Cosmetic Act 1940 And Rules thereunder. 3) The Sample is Misbranded for manner of labelling as given under Rule 34 of Cosmetics Rules 2020.Identification | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Goree Beauty Cream with Lycopene | Batch GB152Mfg Jul 2025 · Exp Jun 2028 | Goree Cosmetics Pvt. Ltd. Made In Pakistan | 1]The sample does not comply for content of mercury i.e. 94.86 PPM, which is more than the limits of 1 part per million (1 ppm) as prescribed for finished cosmetic products under section 39 (5) (b) of cosmetic rules, 2020. 2]The sample is misbranded for manner of labelling as given under rule 34 of cosmetics rules 2020Misbranded | FDAL, MumbaiState lab |
| Goree Beauty Cream with Lycopene | Batch GB152Mfg Jul 2025 · Exp Jun 2028 | Goree Cosmetics (pvt)Ltd | 1) The Sample does not Comply for Content of Mercury i.e. 89733.04 ppm which is more than the Limits of 1 Part per Million (1 ppm) as prescribed for finished Cosmetic Products under Rule 39 (5)(b) of Cosmetic Rules 2020.. 2) The Sample gives Identification for the Presence of Hydroquinone and Mometasone Furoate, hence the Sample is declared as Spurious Vide Rule 17-D(b) of Drug and Cosmetic Act 1940 and Rules thereunder 3) The Sample is Misbranded for manner of labelling as given under Rule 34 of Cosmetics Rules 2020.Identification | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Goree Beauty Cream | Batch GB155Mfg ? · Exp ? | Goree Cosmetics Pvt. Ltd. Made In Pakistan | 1]The sample does not comply for content of mercury I.e. 66.44 PPM, which is more than the limits of 1 part per million (1 ppm) as prescribed for finished cosmetic products under section 39 (5) (b) of cosmetics rules, 2020. 2]The sample is misbranded for manner of labelling as given under rule 34 of cosmetics rules 2020Misbranded | FDAL, MumbaiState lab |
| Glimepiride, Voglibose & Metformin HCL SR Tablets | Batch OT-250933Mfg Aug 2025 · Exp Jul 2027 | Orchid Biotech LtdDelhi | Assay of GlimepirideAssay | SDTL, Andhra Pradesh, VijayawadaState lab |
| Gauze and cotton Tissue BP 1988 | Batch 05Mfg Jun 2026 · Exp May 2029 | Sri Sandana Magalingam Textiles | Threads per 10cm - wrap and weftOther | Drug Testing Laboratory, Chennai-6State lab |
| Gabapentin Tablets IP 300mg | Batch BHT-25021604Mfg Feb 2025 · Exp Jan 2027 | BON-HEUR PharmaceuticalsUttarakhand | The sample does not conform to the I.P. with respect to Dissolution.Dissolution | DTL, JodhpurState lab |
| Gabapentin Tablets IP 100 mg | Batch N2504093Mfg Dec 2025 · Exp Nov 2027 | Intas Pharmaceuticals Ltd.Samardung RoadSikkim | ASSAY OF GABAPENTIN I.P. ?Less than prescribed limit.Assay | SDTL, UttarakhandState lab |
| Frusemide Tablets IP 40 mg | Batch IT01501Mfg Jul 2025 · Exp Jun 2028 | Inducare Pharmaceutical And Research FoundationMaharashtra | The Sample does not Comply with IP Requirements for the Dissolution Test. The Sample is declared as Misbranded vide Rule 96, Section 17(b) and (c) of Drugs and Cosmetics Act, 1940 and Rules 1945, as the Manufacturer stated Name of Active ingredient as Frusemide tablets IP instead of Frusemide IP on sample Blister and Carton.Dissolution | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Frusemide Injection IP 2 ML, 20 MG/2 ML | Batch AV5050Mfg Mar 2025 · Exp Feb 2027 | Alpa Laboratories LtdMadhya Pradesh | The sample does not conform to IP standrads. It fails the test'pH' as per IP, as specified in the Laboratory Protocol.pH | DTL, TVPMState lab |
| Formaldehyde Solution B.P. | Batch F-21Mfg Nov 2025 · Exp Oct 2027 | Vinayak Manutrade (P) LtdRajasthan | The sample does not conforms to the BP with respect to Description and Assay.Assay | DTL, JaipurState lab |
| Folic acid & Ferrous Sulphate Syrup Ip | Batch FSF-220Mfg Oct 2025 · Exp Mar 2027 | Medipol Pharmaceutical India Pvt. LtdHimachal Pradesh | Content of Folic acidOther | FDL, VadodaraState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE011Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the Descriptive part for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE058Mfg Nov 2024 · Exp Oct 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the Descriptive part for tablets as per IP.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE045Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to the IP standards with respect to Description.Description | DTL, ThrissurState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE064Mfg Nov 2024 · Exp Oct 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE009Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE010Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE050Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE022Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | Sample does not conform to IP standards. This particular batch of sample fails in Descriptive part.Other | RDTL , ErnakulamState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE067Mfg Nov 2024 · Exp Oct 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE026Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE016Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE065Mfg Nov 2024 · Exp Oct 2027 | Unicure India LtdUttarakhand | The sample does not conform to IP standards. If fails the tests'Assay' and 'Dissolution' as per IP, as specified in the Laboratory ProtocolAssay | DTL,TVPMState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE023Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to the IP Standards with respect to DescriptionDescription | DTL, ThrissurState lab |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE035Mfg Oct 2024 · Exp Sep 2027 | Unicure India LtdUttarakhand | The sample does not conform to the IP Standards with respect to DescriptionDescription | DTL, ThrissurState lab |
| Flupirtine Maleate and Paracetamol Tablets | Batch T26H291Mfg Aug 2026 · Exp Jul 2028 | Dr. ARS (India) Labs Pvt Ltd | Content of Flupirtine MaleateOther | Drugs Testing Laboratory,Madurai-19State lab |
| Fexofenadine Hydrochloride & Montelukast Sodium Tablets | Batch GB25051Mfg Aug 2025 · Exp Jan 2028 | Devbhoomi PharmaceuticalsUttarakhand | The Content of MontelukastOther | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-647Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-646Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-643Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab |
| Ferrous ascorbate & folic acid tablet IP (100mg/1.5mg) | Batch FAM-648Mfg May 2025 · Exp Oct 2026 | Healer's Lab Unit IIHimachal Pradesh | Description (Cracking)Description | DTL Bhopal,Madhya PradeshState lab |
| Ferrous Ascorbate, Folic Aid & Zinc sulphate Tablets | Batch MPT25035DMfg Apr 2025 · Exp Mar 2027 | Micro Organics Pharmaceuticals (India) Pvt.LtdHimachal Pradesh | Sample does not meets theSpecifications wrt. Disintegration as per IPDisintegration | State Lab, DCL, TelanganaState lab |
| Ferric Carboxymaltose Injection 50 mg/ml | Batch RC26003Mfg Jan 2026 · Exp Dec 2027 | Maan Pharmaceuticals LtdGujarat | The sample does not conform to Manufacturer's specification with respect to test for Particulate matter and Bacterial endotoxins.Particulate matter | CDL, KolkataCDSCO lab |
| Famotidine Tablets USP 40 mg | Batch KT-26012Mfg Mar 2026 · Exp Feb 2028 | Asuwaldi Pharmaceuticals | 1) The Content of Famotidine in the Sample is less (i.e. 78.98% of labelled Amount) than the USP Limit. (USP Limit-Not Less than 90.0% and not more than 110.0% of labelled Amount). 2) The Sample does not Comply with USP Requirements for the Test for Uniformity of Dosage units and Dissolution.Dissolution | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Faiza Beauty cream | Batch 23FBC24Mfg Nov 2025 · Exp Nov 2029 | Poonia Brothers Pvt Ltd | 1.) The Sample gives TLC and HPLC Identification Test for the Presence of Hydroquinone. 2.) The found Content of Hydroquinone in the Sample is 0.76 mg/gm. Hence, the Sample is declared as Spurious Vide Rule 96: Section 17D(b) of Drugs and Cosmetics Act 1940 and Rules thereunder.Identification | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| FORMALDEHYDE SOLUTION B.P. | Batch F-34Mfg May 2026 · Exp Apr 2028 | Vinayak Manutrade (P) LtdRajasthan | The sample does not conforms to the BP with respect to Assay.Assay | DTL, JaipurState lab |
| FORMALDEHYDE SOLUTION B.P. | Batch F-27Mfg Dec 2025 · Exp Nov 2027 | Vinayak Manutrade (P) LtdRajasthan | The sample does not conforms to the BP with respect to Assay.Assay | DTL, JaipurState lab |
| Etizolam Orally Disintegrating Tablets | Batch EZJT26001Mfg Feb 2026 · Exp Jan 2028 | Ravian Life Science Pvt. LtdUttarakhand | As per Drugs &Cosmetics Act Rule 127 (2), the common name of colour in not mentioned anywhere on the label.Labelling | SDTL, PunjabState lab |
| Esomeprazole Gastro-Resistant Tablets IP 40 mg | Batch NHV26001Mfg Mar 2026 · Exp Feb 2028 | Windlas Biotech Limited (Plant-2)Uttarakhand | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab |
| Drotaverine Hydrocloride suspension | Batch A20718Mfg Apr 2025 · Exp Mar 2027 | Aspen LifesciencesPunjab | content - Drotaverine HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Doxycycline Tablets USP 100 mg | Batch DXT25003Mfg Oct 2025 · Exp Sep 2027 | Vivek Pharmachem (India) LtdRajasthan | The Sample does not conform to the USP standards with respect to the tests DissolutionDissolution | DTL, ThrissurState lab |
| Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate and Menthol Syrup 50 ml | Batch 26007Mfg Feb 2026 · Exp Jan 2028 | Riemann Labs Pvt. LtdMadhya Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of MentholAssay | RDTL, ChandigarhCDSCO lab |
| Dicyclomine Tablets I.P 10 mg | Batch THY25008AMfg May 2025 · Exp Apr 2027 | Hindustan Laboratories LimitedMaharashtra | DescriptionDescription | RDTL, Hubli, KarnatakaState lab |
| Dicyclomine Hydrochloride Tablets IP 20 mg | Batch BGT-2601Mfg Mar 2026 · Exp Feb 2029 | Suprex Laboratories | Assay for Dicyclomine HydrochlorideAssay | RDTL, Bellary, KarnatakaState lab |
| Diclovis Tablets | Batch PT-03/68Mfg Mar 2025 · Exp Feb 2027 | Progressive Lifescience Pvt. Ltd. LatherdevahoonUttarakhand | Description having mottled appeareanceDescription | DTL Jabalpur Madhya PradeshState lab |
| Diclofenac Sodium Tablet 50 mg | Batch T-2565Mfg ? · Exp Jun 2028 | Strain Healthcare 115 | The sample does not conforms to the claim with respect to Assay of Diclofenac Sodium.Assay | DTL, JaipurState lab |
| Diclofenac Sodium Injection I.P. | Batch SGALD26004Mfg Feb 2026 · Exp Jan 2028 | SGS Pharmaceuticals Pvt. LtdUttarakhand | The sample does not conforms to I.P. in the respect of content of diclofenac sodium.Other | ALIGARH, Uttar PradeshState lab |
| Diclofenac Sodium IP | Batch DFS-2602236Mfg Feb 2026 · Exp Jan 2031 | Sara Export Ltd | The sample does not conform to IP with respect to Appearance of solution and Loss on dryingLoss on drying | LUCKNOW, Uttar PradeshState lab |
| Diclofenac Sodium Gastro-Resistant Tablets IP 50 mg | Batch EN26014Mfg Apr 2026 · Exp Mar 2028 | Ind-Swift Laboratories Limited | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab |
| Diclofenac Sodium 50 mg + Caffeine 50 mg Tablets) | Batch T25-07Mfg Jun 2025 · Exp May 2028 | Strain Healthcare 115 | The sample does not conforms to the claim with respect to Caffeine (Anhydrous) Nil.Other | DTL, JaipurState lab |
| Diclofenac Sodium 50 mg + Caffeine 50 mg Tablets | Batch T25-08Mfg Jul 2025 · Exp Jun 2028 | Strain Healthcare 115 | The sample does not conforms to the claim with respect to Caffeine (Anhydrous) Nil.Other | DTL, JaipurState lab |
| Diclofenac Diethylamine, Mnethyl Salicylate, Linseed oil, Menthol Gel | Batch BL-037Mfg Sep 2025 · Exp Aug 2027 | Brit LifesciencesHimachal Pradesh | content - Methyl Salicylate and mentholOther | Drug Testing Laboratory, Madurai-19State lab |
| Diclofenac Diethylamine, Mnethyl Salicylate, Linseed oil, Menthol Gel | Batch CCE26040AMfg Feb 2026 · Exp Jan 2028 | Cent Cure Pvt. LtdHimachal Pradesh | content - Methyl SalicylateOther | Drug Testing Laboratory, Madurai-19State lab |
| Diclofenac Diethylamine, Mnethyl Salicylate, Linseed oil, Menthol Gel | Batch E281Mfg Aug 2025 · Exp Jul 2027 | Neptune Life Sciences Pvt. LtdHimachal Pradesh | content - Methyl SalicylateOther | Drug Testing Laboratory, Chennai-6State lab |
| Diazepam Injection IP | Batch I-3898Mfg May 2026 · Exp Apr 2028 | Jackson Laboratories Pvt. LtdPunjab | The sample does not conform to IP in respect of Description, Particulate Matter, pH arIdentification, hence SpuriousDescription | LUCKNOW, Uttar PradeshState lab |
| Diazepam Injection IP | Batch I-408-BMfg Apr 2025 · Exp May 2027 | Jackson Laboratories Pvt. LtdPunjab | The sample does not conform to IP with respeet to Description, Particulate Matter, pII & IdentificationDescription | LUCKNOW, Uttar PradeshState lab |
| Dextrose and Sodium Chloride Injection I.P. | Batch F51528Mfg Dec 2025 · Exp Nov 2028 | Higgs HealthcareHimachal Pradesh | The sample does not conform to I.P. with respect to Assay of Sodium Chloride and DextroseAssay | CDL, KolkataCDSCO lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, Chlorpheniramine Maleate Syrup | Batch 2601646Mfg Jan 2026 · Exp Dec 2027 | Saar Biotech Pvt. LtdHimachal Pradesh | content- Phenylephrine HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Malete Syrup | Batch DPL-717Mfg Mar 2026 · Exp Feb 2028 | Dexbio Pharma Pvt LtdUttarakhand | content - Phenylephrine HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| DICLOFENAC SODIUM TABLETS IP 50mg | Batch S635001Mfg Sep 2025 · Exp Aug 2027 | Goa Antibiotics & Pharmaceuticals LtdGoa | Misbranded-Incorrect LabellingMisbranded | DTL, PuducherryState lab |
| Cyproheptadine Hydrochloride IP Syrup | Batch DL0207Mfg Mar 2026 · Exp Feb 2028 | Dexter Formulation Pvt. Ltd | pHpH | Drug Testing Laboratory, Madurai-19State lab |
| Cyproheptadine HCl and Tricholine Citrate Syrup | Batch LXL-26103Mfg Mar 2026 · Exp Feb 2028 | Lexus India LimitedUttarakhand | The sample does not conform as per Manufacturers specification with respect to the test for Average filled volume volumeOther | CDTL, MumbaiCDSCO lab |
| Cotton Roll Bandage 15 CMX3MTRSX10 ROLLS | Batch RB28Mfg Feb 2026 · Exp Jan 2029 | Jai Krishna EnterprisesTamil Nadu | Sample does not comply Ends, Picks, Mass for cotton rolled Bandage as per BIS 863:2023. Medical Textiles- Cotton Bandage cloth specifications.Other | State Lab, DCL, TelanganaState lab |
| Compound Sodium Lactate Injection IP | Batch CGF250546Mfg May 2025 · Exp Apr 2027 | Haseeb Pharmaceuticals Pvt. LtdMaharashtra | The sample does not conform to I.P. with respect to test for 'Bacterial endotoxins'.Bacterial endotoxins | CDL, KolkataCDSCO lab |
| Compound Sodium Lactate Injection IP | Batch P2605F048Mfg Mar 2026 · Exp Feb 2028 | MKA Remedies Pvt. Ltd | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Compound Sodium Lactate Injection I.P. (RL 500 ml) | Batch EE26A009Mfg Jan 2026 · Exp Dec 2027 | Hindustan PolyfabHimachal Pradesh | The sample does not conform to I.P. with respect to test for 'Sterility'.Sterility | CDL, KolkataCDSCO lab |
| Cofixime, Cloxacillin & Lactic Acid Bacillus Tablets | Batch 6926C002Mfg Mar 2026 · Exp Feb 2028 | Malik Lifesciences Pvt. LtdUttarakhand | The sample does not conform to declared formula in respect of Disintegration Test.Disintegration | LUCKNOW, Uttar PradeshState lab |
| Codeine Phosphate & Triprolidine Hydrochloride Syrup | Batch WW126017Mfg Apr 2026 · Exp Mar 2028 | Windlas Biotech Limited.(Plant-2) Khasrano.141 to 143&145Uttarakhand | Identification and Content of Codeine Phosphate & Triprolidine HydrochlorideIdentification | FDL, VadodaraState lab |
| Co-trimoxaole Tablets IP | Batch CHPLT1004Mfg Dec 2025 · Exp Nov 2027 | Cureza Healthcare Pvt. LtdMadhya Pradesh | The Sample does not Comply for Description as-- uneven light Brown coloured Spots are observed all over the Surface of Almost all the Tablets.Description | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Clopidogrel and Aspirin Capsules | Batch SIH0304AMfg Feb 2026 · Exp Nov 2027 | Sun Pharma Laboratories LtdSikkim | The Sample does not Comply for description, as- the Capsule Containing Lumps of Multi-Coloured granulesDescription | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Clopidogrel & Aspirin Tablets IP | Batch CAS2504Mfg Dec 2025 · Exp Nov 2027 | Applied Communication & ControlsUttarakhand | The Sample does not conform to IP standards with respect to the test Dissolution. For Aspirin, Related Substances for Aspirin and Assay of Aspirin.Assay | RDTL , ErnakulamState lab |
| Clonazepam Tablets IP 0.5 mg, Clam 0.5 Tablets | Batch NT240146Mfg Aug 2024 · Exp Jul 2027 | Oxford PharmaUttarakhand | The Sample does not conform to IP Standards. It fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL, TVPMState lab |
| Clobetasol Propionate, Ofloxacin, Miconazole Nitrate and zinc Sulphate Lotion | Batch SVP-495Mfg Nov 2025 · Exp Oct 2028 | Solar PharmaceuticalsPunjab | Clobetasol Propionate, Ofloxacin, Miconazole NitrateOther | Drug Testing Laboratory, Madurai-19State lab |
| Clobetasol Propionate Cream IP | Batch 689Mfg Dec 2025 · Exp Nov 2027 | Solar PharmaceuticalsPunjab | content- Clobetasol propionateOther | Drug Testing Laboratory, Madurai-19State lab |
| Ciprofloxacin Tablets BP 500 mg | Batch AT2514Mfg ? · Exp Feb 2030 | Ultra Imports & Exports LLPDelhi | The sample does not conforms to the BP with respect to Assay of Ciprofloxacin Hydrochloride equivalent to Ciprofloxacin.Assay | DTL, JaipurState lab |
| Chlorpheniramine Maleate Tablets IP 4mg | Batch CMM25009Mfg Dec 2025 · Exp Nov 2027 | Danish Health Care (P) Ltd | content- Chlorpheniramine MaleateOther | Drug Testing Laboratory, Madurai-19State lab |
| Chlorhexidine Gluconate Solutions I.P. | Batch PXD-16Mfg Jan 2026 · Exp Dec 2027 | Pharma Asia Drug 20-21Madhya Pradesh | The content of chlorhexidine gluconate in the sample (i.e. 22.80 % of the stated amount) is less than the IP limit. (I.P. LIMIT ? 95 % TO 105 % of the stated amount) therefore, the drug is declared as misbranded vide rule 96, section 17 (b) of drugs and cosmetics act 1940 and rules 1945 thereunder.Misbranded | FDAL, MumbaiState lab |
| Cetirizine Hydrocloride and Ambroxol Hydrochloride Syrup | Batch P0126002LMfg Jan 2026 · Exp Dec 2027 | Pharma Roots HealthcareHimachal Pradesh | content - Ambroxol HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Cefuroxime Axetil Tablets IP 250 mg | Batch CT-163AMfg Jun 2025 · Exp May 2027 | Vee LaboratoriesHimachal Pradesh | The sample is not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab |
| Ceftriaxone for Injection IP | Batch ADH5045Mfg Aug 2025 · Exp Jul 2027 | Actinova Pvt. LtdHimachal Pradesh | The sample does not conforms to I.P. in the respect of content of ceftriaxone.Other | ALIGARH, Uttar PradeshState lab |
| Ceftriaxone & Tazobactam Injection | Batch VD251048Mfg Nov 2025 · Exp Oct 2027 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules with respect to test for Sterility (Powder for Injection) and Assay/content of Tazobactam and Ceftriaxone.Assay | CDL, KolkataCDSCO lab |
| Ceftriaxone & Sulbactam for Injection IP | Batch VD251064Mfg Nov 2025 · Exp Oct 2027 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conforms to I.P., in respect of clarity of solution, particulate matter and Assay of both Ceftriaxone & Sulbactam,Assay | Agra, Uttar PradeshState lab |
| Ceftriaxone Injection IP 1.0 gm | Batch HD1304EMfg May 2025 · Exp Apr 2027 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conforms to I.P. in respect of Particulate matterParticulate matter | Gorakhpur, Uttar PradeshState lab |
| Ceftriaxone Injection IP 1000 mg | Batch RKCXBP003Mfg Jan 2026 · Exp Dec 2027 | RK Life Care INCHaryana | The sample does not conform to I.P. in the respect of Clarity of solution, Particulate matter and misbranded with labellingParticulate matter | ALIGARH, Uttar PradeshState lab |
| Ceftriaxone Injection IP | Batch DIDB5105Mfg Feb 2026 · Exp Jan 2028 | Francis Remedies (India) Pvt. LtdUttarakhand | The sample does not conform to I.P. in the respect of Clarity of solution and Particulate matter.Particulate matter | ALIGARH, Uttar PradeshState lab |
| Cefpodoxime Proxetil Oral Suspension IP 100 mg/5ml | Batch TGD05250017Mfg May 2025 · Exp Apr 2027 | T & G MedicareHimachal Pradesh | Content of CefpodoximeOther | LUCKNOW, Uttar PradeshState lab |
| Cefpodoxime Proxetil Dispersible Tablets | Batch UCT-26285AMfg Jul 2026 · Exp Jun 2028 | Ultra Drugs Pvt. LtdHimachal Pradesh | DescriptionDescription | SDTL, PunjabState lab |
| Cefpodoxime Proxetil | Batch BL-211B26Mfg Feb 2026 · Exp Jan 2028 | Altru ap Pharmaceuticals Regd office: Nowhera Sgr Kmr. Jand K (India)190011. Admin office: 1st Floor A-24 B Golden Leaf Colony | The sample fails in Description and does not conform to IP 2022 requirements with respect to Uniformity of weight and AssayAssay | DTL, Dalgate Srinagar KashmirState lab |
| Cefpodoxime Dispersible Tablets 200 mg | Batch T25044Mfg Feb 2025 · Exp Jan 2027 | HML Pharmaceuticals LLPChhattisgarh | IDENTIFICATION TEST: No peak observed in Chromatogram of Cefpodoxime I.P. (Does not comply with I.P.). 02. ASSAY OF CEFPODOXIME TRIHYDRATE I.P. ?NIL.Assay | SDTL, UttarakhandState lab |
| Cefpodoxime & Potassium Clavulanate tablets | Batch VT260343Mfg May 2026 · Exp Oct 2027 | VADSP PharmaceuticalsHimachal Pradesh | Sample Does not complies for the Assay of Cefpodoxime and Clavulanic Acid, hence it is Not of Standard Quality.Assay | State Lab, DCL, TelanganaState lab |
| Cefixime, Ornidazole and Lactic Acid Bacillus Tablets | Batch EBL-421Mfg Apr 2026 · Exp Mar 2028 | Ticoma PharmaciaPunjab | The sample does not conform to declared formula in respect of Content of anhydrous CefiximeOther | Gorakhpur, Uttar PradeshState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus | Batch PP-242154Mfg Feb 2025 · Exp Sep 2027 | Park Pharmaceuticals 272Haryana | ASSAY OF CEFIXIME I.P. & AZITHROMYCIN- Less than prescribed limit.Assay | SDTL, UttarakhandState lab |
| Cefixime and Lactic Acid Bacillus Tablets | Batch MHPL-733Mfg Dec 2025 · Exp Nov 2027 | Medinok Healthcare Pvt. LtdPuducherry | tests for Uniformity of Dispersion and Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| Cefixime Tablets I.P. 200 mg | Batch T6229Mfg Jul 2026 · Exp Jun 2028 | Zest PharmaMadhya Pradesh | DescriptionDescription | SDTL, PunjabState lab |
| Cefixime Tablets I.P. 200 mg | Batch T6228Mfg Jul 2026 · Exp Jun 2028 | Zest PharmaMadhya Pradesh | DescriptionDescription | SDTL, PunjabState lab |
| Cefixime Tablets I.P. 200 mg | Batch T6227Mfg Jul 2026 · Exp Jun 2028 | Zest PharmaMadhya Pradesh | DescriptionDescription | SDTL, PunjabState lab |
| Cefixime Oral Suspension IP Dry Syrup 100mg/5ml | Batch CADC-02Mfg Feb 2025 · Exp Jan 2027 | Nestor Pharmaceuticals Limited IIHaryana | The Sample does not conform to IP Standards. It fails the tests Water and Assay as per IP as specified in the Laboratory ProtocolAssay | DTL, TVPMState lab |
| Cefixime Dispersible Tablets I.P. | Batch PYITL003Mfg May 2025 · Exp Apr 2027 | Laborate Pharmaceuticals India LtdHimachal Pradesh | DESCRIPTION ? TABLETS HAVING BROWN COLOR SPOTS ON SURFACE.Description | SDTL, UttarakhandState lab |
| Capsules of L-Arginine, Ubidecarenone, Lycopene, Vitamins and Piperine | Batch CJO02AAAMfg Nov 2025 · Exp Jul 2027 | Pure & Cure Healthcare Pvt. LtdUttarakhand | content- Pyridoxine hydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Calcium and Vitamin D3 Tablets IP (500 mg +250 IU) (Calcium 500 mg & Vitamin D3 250 IU) | Batch CUTC-250Mfg Dec 2025 · Exp Nov 2027 | Nestor Pharmaceuticals Limited IIHaryana | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab |
| Calcium Carbonate With Vitamin D3 Tablets IP | Batch PB2607001Mfg Jul 2026 · Exp Jun 2028 | Kanha BiogeneticHimachal Pradesh | 1. The Content of Elemental Calcium found to be 400.8 mg per tablet (80.20%) against label claim of 500 mg per tablet. 2. The content of Vitamin D3 found to be 4.495 IU per tablet (1.798%) against label claim of 250 IU per tablet. 3. Dissolution Elemental Calcium does not complies as per IP 2026.Dissolution | SDTL, PunjabState lab |
| Calcitriol, Calcium Carbonate, Zinc, Magnesium, Vatamin K2 7, Methylfolate Soft Gelatin Capsules | Batch D26SCY01Mfg Jan 2026 · Exp Dec 2027 | Caspian PharmaceuticalsHimachal Pradesh | The sample does not conforms to standard quality in respect of Disintegration testDisintegration | Agra, Uttar PradeshState lab |
| Buprenorphine and Naloxone sublingual Tablets I.P. 2mg+ 0.5mg | Batch SLTF26030Mfg Jun 2026 · Exp May 2028 | Swift Life Sciences Pvt. LtdUttarakhand | 1. The content of Buprenorphine found to be 1.74 mg per tablet (87%) against labelled claim of 2.0 mg per tablet. 2. The content of Naloxone found to be 0.432 mg per tablet (86.40%) against labelled claim of 0.5 mg per tablet.Labelling | SDTL, PunjabState lab |
| Buprenorphine Injection IP 2 ml | Batch BUP324004Mfg Feb 2025 · Exp Jan 2027 | Indus Pharma Pharma Pvt. LtdRajasthan | The sample does not conform to I.P. in respect of Identification & Particulate matter, hence SpuriousIdentification | LUCKNOW, Uttar PradeshState lab |
| Buprenorphine HCI and Naloxone Sublingula Tablets I.P. | Batch SLTE26026Mfg May 2026 · Exp Apr 2028 | Swift Life Sciences Pvt. LtdUttarakhand | The content of Buprenorphine found to be 0.451 mg per tablet (112.75%) against labelled claim of 0.4 mg per tabletLabelling | SDTL, PunjabState lab |
| Bupivacaine Injection IP 0.5% | Batch SP26013Mfg Mar 2026 · Exp Feb 2028 | Shukra Pharmaceuticals LtdGujarat | The sample does not conform to IP with respect to test for 'Particulate matter and is also not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP | Batch MN24369AMfg Mar 2025 · Exp Feb 2027 | Medizia BiotechHimachal Pradesh | The sample does not conform to U.S.P. with respect to test for 'pH', 'Visible Particulates In Injection' and is also not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | Batch L-2507011Mfg Jul 2025 · Exp Jun 2027 | Rivpra Formulation Pvt. LtdUttarakhand | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Bromhexine Hydrochloride, Terbutaline SulphateAssay | RDTL, ChandigarhCDSCO lab |
| Bithionol Sulphoxide Bolus | Batch V260305Mfg Mar 2026 · Exp Jun 2027 | Apple Biotech Healthcare Pvt. LtdPunjab | The sample does not conform to declared formula in respect of content of Bithionol Sulfox-deOther | VARANASI, Uttar PradeshState lab |
| Bisacodyl Tablets IP 5 mg | Batch 05528Mfg Dec 2025 · Exp Nov 2028 | Healthy Life Pharma Pvt. LtdMaharashtra | Content of BisacodylOther | FDL, VadodaraState lab |
| Bisacodyl Tablets IP 5 mg | Batch 08676Mfg Mar 2026 · Exp Feb 2029 | Healthy Life Pharma Pvt. LtdMaharashtra | Content of BisacodylOther | FDL, VadodaraState lab |
| Betamethasone Sodium Phosphate Tablets IP 0.5 mg | Batch T50169Mfg May 2025 · Exp Apr 2027 | Zenith Drugs Pvt. LtdMadhya Pradesh | Assay for BetamethasoneAssay | RDTL, Bellary, KarnatakaState lab |
| Atorvastatin Tablets IP 40mg | Batch SBT-933Mfg Mar 2026 · Exp Feb 2028 | Sarthak Biotech Pvt. Ltd | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Atorvasratin.Dissolution | RDTL, GuwahatiCDSCO lab |
| Aspirin Tablets IP 150mg | Batch TAS25011ALMfg Jun 2025 · Exp May 2027 | Hindustan Laboratories LimitedMaharashtra | DissolutionDissolution | Drug Testing Laboratory, Chennai-6State lab |
| Aspirin Tablets I.P. 300 mg | Batch LPT2526188Mfg Jun 2025 · Exp May 2027 | Lannet Pharmaceuticals Pvt. Ltd | The Sample does not Comply with IP Requiremnts for the Dissolution Test.Dissolution | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Artesunate Injection IP | Batch 25GF23MMfg Jun 2025 · Exp May 2027 | MMG HelathcareHimachal Pradesh | The sample does not conform to I.P. in the respect of Clarity of solution and Particulate matter.Particulate matter | ALIGARH, Uttar PradeshState lab |
| Ampicillin Capusules IP 500mg | Batch ATBC1301Mfg Nov 2025 · Exp Oct 2027 | Unicure India Ltd. C-21 | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab |
| Amoxycillin, Cloxacillin & Lactic Acid Bacillus Capsules) | Batch SBC-25059Mfg Sep 2025 · Exp Aug 2027 | Spectrum Formulation Pvt. LtdUttarakhand | Description and Assay for CloxacillinAssay | DTL, Bengaluru, KarnatakaState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch ABT25719Mfg Feb 2026 · Exp Jul 2027 | Alexa PhamaceuticalsHimachal Pradesh | The sample does not conform to IP with respect to content of Amoxycillin & Clavulanic acid on the basis of tests doneOther | LUCKNOW, Uttar PradeshState lab |
| Amoxycillin and Potassium Clavulanate Oral Suspension IP 228.5 mg | Batch GPF01ABBMfg Feb 2026 · Exp Jul 2027 | Malik Lifesciences Pvt. LtdUttarakhand | The sample for the reasons given be.ow:- does not conforms to I.P. in respect of content of Amoxycillin and Clavulanic Acid.Other | Meerut, Uttar PradeshState lab |
| Amoxycillin and Potassium Clavulanate Oral Suspension | Batch GPD26004Mfg Jan 2026 · Exp Jun 2027 | Affy ParentalsHimachal Pradesh | The sample does not conform to I.P. in respect of content of Clavulanic Acid & Water contentWater content | MEERUT, Uttar PradeshState lab |
| Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets | Batch ABT25838Mfg Mar 2026 · Exp Aug 2027 | Alexa PharmaceuticalsHimachal Pradesh | Identification & Assay of Clavulanic Acid and Assay of AmoxycillinAssay | SDTL, Andhra Pradesh, VijayawadaState lab |
| Amoxycillin & Potassium Clavulanate Tablets I.P | Batch HPT25002Mfg Jun 2025 · Exp Nov 2026 | Hariom PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay and Dissolution" of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab |
| Amoxycillin & Potassium Clavulanate Tablets | Batch ABT26059Mfg Apr 2026 · Exp Sep 2027 | Alexa PhamaceuticalsHimachal Pradesh | The sample does not conform to IP in respect of Identification of Clavulanic Acid, hence spurious and the sampledoes not conform to I.P., in respect of Assay of Amoxycillin.Assay | LUCKNOW, Uttar PradeshState lab |
| Amoxycillin & Potassium Clavulanate Oral Suspension IP | Batch B7AEY043Mfg Oct 2025 · Exp Mar 2027 | Copmed Pharmaceuticals Pvt.LtdHimachal Pradesh | The sample does not conforms to I.P. in respect of Content of AmoxycillinOther | LUCKNOW, Uttar PradeshState lab |
| Amoxycillin & Potassium Clavulanate Injection IP 1200 mg | Batch D0092509AMfg Feb 2025 · Exp Jan 2027 | Protech TelelinksHimachal Pradesh | The sample does not conform to IP with respect to the Assay of Clavulanic Acid.Assay | CDL, KolkataCDSCO lab |
| Amitripyline Tablets IP 25mg | Batch GAMT2Mfg Jun 2025 · Exp May 2027 | Super Formulations Pvt. Ltd | content- Amitriptyline HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab |
| Ambroxol, Terbutaline & Guaiphenesin Cough Expectorant | Batch GRL600425Mfg Apr 2025 · Exp Mar 2027 | Guinness Remedies Pvt. Ltd | The sample does not conform to declared formula with respect to Identity test for Ambroxol Hydrochloride." Sample gives negative identity test for Diethylene Glycol (DEG) & Ethylene Glycol (EG).Other | LUCKNOW, Uttar PradeshState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | Batch L15017AMfg Sep 2025 · Exp Aug 2027 | Navkar LifesciencesHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin Syrup | Batch T3-13Mfg Apr 2025 · Exp Mar 2027 | Swiss India LaboratoriesHimachal Pradesh | TESTS FOR ASSAY (CONTENT) OF AMBROXOL HYDROCHLORIDEAssay | DTL, DelhiState lab |
| Alprazolam Tablets IP 0.5 mg | Batch 60098Mfg Feb 2026 · Exp Jan 2028 | Uniza Lifecare Pvt. LtdGujarat | The sample does not conform to IP in respect of DissolutionDissolution | LUCKNOW, Uttar PradeshState lab |
| Albendazole Tablets IP 400mg) | Batch 418TAT001Mfg Apr 2025 · Exp Mar 2028 | Swiss Garnier Life SciencesHimachal Pradesh | content- AlbendazoleOther | Drug Testing Laboratory, Chennai-6State lab |
| Albendazole Tablets IP 400 mg | Batch UT-1821Mfg Feb 2025 · Exp Jan 2027 | Clevus Lifesciences | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Albendazole Tablets IP 400 mg | Batch 370725005Mfg Sep 2025 · Exp Aug 2028 | Revenbhel Healthcare Pvt LtdJammu & Kashmir | The sample does not conform to IP standards. It fails the test 'Dissolution' as per IP as specified in the Laboratory Protocol.Dissolution | DTL, TVPMState lab |
| Albendazole Tablets 400 mg | Batch MI012501Mfg Jul 2025 · Exp Jun 2028 | Nhika PharmaceuticalsMaharashtra | The Sample does not Comply with IP Requirements for the Dissolution Test. The sample is declared as MisbrandedDissolution | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Adrenaline Bitartrate InJ. I.P. | Batch AN-215Mfg Feb 2026 · Exp Jul 2027 | Amba Research LaboratoriesBihar | The sample does not conform to IP with respect to test for "Particulate matter", "pH", "Assay/content of Adrenaline and is also not of standard quality for the reason stated under "Description".Assay | CDL, KolkataCDSCO lab |
| Activated Dimethicone Magnesium Hydroxide Aluminium Hydroxide gel estimated as Aluminium Oxide | Batch PMNE051Mfg Jun 2024 · Exp May 2027 | Naxpar Pharma Pvt. Ltd. 182Himachal Pradesh | DescriptionDescription | SDT&RL, BhubanesearState lab |
| Aceclofenac, Paracetamol &Chlorozoxazone Tablets | Batch HT25871Mfg Dec 2025 · Exp Nov 2027 | Habitare Pharma Pvt.LtdHimachal Pradesh | Sample FENELA-MR tablets does not comply test for Disintegration as per IP 2022Disintegration | State Lab, DCL, TelanganaState lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets) | Batch TG25-2242FMfg Dec 2025 · Exp Nov 2027 | Athens Life SciencesHimachal Pradesh | The Content of Serratiopeptidase in the Sample is less (i.e. 32.33% of Stated Amount) than Schedule V Limit. (Schedule V Limit:- Not less than 90% of Stated Amount)Other | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab |
| Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Batch AT25-0938AMfg Nov 2025 · Exp Oct 2027 | Aspo Pharmaceuticals LLPHimachal Pradesh | The sample does not conform to declared formula, in respect of content of Aceclofenac.Other | LUCKNOW, Uttar PradeshState lab |
| Aceclofenac and Paracetamol Tablets | Batch T24K557CMfg Nov 2024 · Exp Oct 2026 | Bajaj FormulationsUttarakhand | TESTS FOR UNIFORMITY OF WEIGHT.Uniformity of weight/content | DTL, DelhiState lab |
| Aceclofenac Tablets IP 100mg | Batch M26800003Mfg Mar 2026 · Exp Feb 2028 | Dr.Miltons Laboratories Private Limited | DescriptionDescription | Drug Testing Laboratory, Madurai-19State lab |
| Aceclofenac & Paracetamol Tablets | Batch UT260046Mfg Apr 2026 · Exp Mar 2028 | VADSP PharmaceuticalsHimachal Pradesh | content- ParacetamolOther | Drug Testing Laboratory, Madurai-19State lab |
| Absorbent cotton Gauze IS 758 (Non-Sterile) | Batch AG67/25Mfg Dec 2025 · Exp Nov 2028 | Pankajavale Product | AbsorbencyOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Gauze IS 758 | Batch G 43Mfg Apr 2026 · Exp Mar 2029 | Muthu Surgicals | Threads / dm(ends), mass, Length and widthOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Gauze (Super Deluxe) IS 758 (NOT STERILIZED) | Batch G 43Mfg Apr 2026 · Exp Mar 2029 | Muthu Surgicals | Width and AbsorbencyOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool IP | Batch 2121Mfg Dec 2025 · Exp Nov 2029 | Jind SurgicalsHaryana | Fluorescence, Neps and Sulphated AshOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool IP | Batch R/0500/197Mfg Jul 2025 · Exp Jun 2029 | Mohini Health & Hygiene LtdMadhya Pradesh | sinking time and NepsOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool IP | Batch 950Mfg Mar 2026 · Exp Feb 2029 | Rishabh Texco Pvt LtdRajasthan | Fluorescence and sulphated AshOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool IP | Batch R/0500/355Mfg Dec 2025 · Exp Nov 2029 | Mohini Health & Hygiene LtdMadhya Pradesh | NepsOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool IP | Batch 1662Mfg Mar 2026 · Exp Feb 2028 | Mamta Spinners Pvt Ltd | Surface active substances, Fluorescence, Neps and sulphated AshOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool I.P. | Batch R/0500/347Mfg Dec 2025 · Exp Nov 2029 | Mohini Health & Hygiene LtdMadhya Pradesh | NepsOther | Drug Testing Laboratory, Chennai-6State lab |
| Absorbent Cotton wool I.P | Batch 911Mfg Nov 2025 · Exp Oct 2028 | Rishabh Texco Pvt LtdRajasthan | Sulphated Ash, water soluble substances and FluorescenceWater content | Drug Testing Laboratory, Chennai-6State lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Lactic Acid Bacillus Tablets (120 M) | BDS25003 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (330 rows). Revised CDSCO lists are diffed on each monthly rebuild.